FABP4, GINS2 and CBX7 Expression in Cancer Cervix Tissues: Clinical, Pathological and Prognostic Implications

Area of Science:

• Oncology
• Molecular Biology
• Biomarker Discovery

Background:

• Cervical cancer metastasis to pelvic lymph nodes leads to poor survival rates.
• Early detection of lymph node status is crucial for effective cervical cancer treatment.
• There is a need for novel predictive biomarkers for cervical cancer lymph node involvement.

Purpose of the Study:

• To evaluate the expression of FABP4, GINS2, and CBX7 in cervical cancer tissues.
• To determine the prognostic and predictive roles of these biomarkers in lymph node metastasis.
• To assess the association between biomarker expression and clinicopathological parameters.

Main Methods:

• Immunohistochemistry was used to assess FABP4, GINS2, and CBX7 expression in cervical cancer tissues.
• The study analyzed the correlation between biomarker expression and various clinicopathological and prognostic factors.
• Tissue samples were collected from patients diagnosed with cervical cancer.

Main Results:

• High FABP4 and GINS2 expression and low CBX7 expression correlated with older age, larger tumor size, and advanced FIGO stage.
• These expression patterns were also associated with lymphovascular invasion, parametrial infiltration, and chemotherapeutic resistance.
• The findings indicated a link between biomarker expression and increased tumor recurrence.

Conclusions:

• FABP4 and GINS2 exhibit oncogenic roles, while CBX7 acts as a tumor suppressor in cervical cancer.
• These biomarkers are associated with unfavorable clinicopathological features and poor survival outcomes.
• FABP4, GINS2, and CBX7 show potential as preoperative predictive biomarkers for lymph node metastasis in cervical cancer, aiding in treatment planning.